Changes in Iron Metabolism Induced by Anti-Interleukin-6 Receptor Monoclonal Antibody are Associated with an Increased Risk of Infection

(1) Background: Treatment of patients with rheumatoid arthritis (RA) with an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody (tocilizumab) has been found to influence iron metabolism. The objective of the present study was to ascertain whether changes in iron metabolism induced by anti-IL-6R bio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Renata Ribeiro, Frederico Batista, Filipe Seguro Paula, José Delgado Alves
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2019-06-01
Colecção:Pharmaceuticals
Assuntos:
iron
hepcidin
ferroportin
Interleukin-6
infection
rheumatoid arthritis
Acesso em linha:https://www.mdpi.com/1424-8247/12/3/100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados